DYNAMICS OF MICROCIRCULATION INDEX CHANGES IN ISCHEMIC SPINAL MARROW EXPOSED TO RECOMBINANT ERYTHROPOIETIN AND LASER EMISSION (experimental study)


Cite item

Full Text

Abstract

Aim. To study the dynamics of microcirculation index in the focus of experimental spinal marrow ischemia in rats exposed to recombinant erythropoietin and laser emission. Materials and methods. The work was carried out on 80 sexually mature rats, divided into four test series - 20 animals each. In animals of series one, the control group, the spinal marrow ischemia was modeled. In series two, animals were intraperitoneally introduced 1000 ME of recombinant erythropoietin in 3, 24 and 48 hours. Animals of series three after the operation were exposed to skin irradiation with diode laser in the zone of ischemia. In test series four, laser emission of the ischemic focus was combined with introduction of recombinant erythropoietin. Assessment of microcirculation index was performed in animals of all the series during each period of the test using the unit LAKK-01 (Russian Federation) with subsequent mathematical and statistical processing by means of the program “Lasma” (Russian Federation). Results. The study results reliably indicate that recombinant erythropoietin possesses an antiapoptotic and antihypoxic effect, stimulates angio- and neurogenesis, but when exposed to laser emission of infrared range it promotes strengthening of microcirculation in the focus of ischemia. Conclusions. Combined effect of recombinant erythropoietin and laser emission in the zone of ischemic lesion of the spinal marrow significantly raises the local blood flow. It is accompanied by an early regress of neurological disorders and activation of behavior in animals.

References

  1. Головнева Е. С. О роли тучных клеток в стимуляции процесса неоангиогенеза в ответ на воздействие высокоинтенсивного лазерного излучения. Лазерная медицина 2001; 5: 29-32.
  2. Козель А. И., Попов Г. К., Гиниатуллин Р. У., Астахова Л. В., Володченко А.М. Способ лечения ишемии спинного мозга в эксперименте. Патент РФ на изобретение № 2496513 от 20.10.2013 г.
  3. Онищенко Л. С., Гайкова О. Н., Янишевский С. Н. Изменения в очаге экспериментального ишемического инсульта под воз- действием нейротропных препаратов. Морфология 2006; 6: 40-46.
  4. Суфианова Г. З., Усов Л. А., Суфианов А. А. Новая малоинвазивная модель ишемии спинного мозга у крыс. Бюллетень экспериментальной биологиии медицины 2002; 133 (1): 116-120.
  5. Celik M., Gokmen N., Erbayraktar S., Akhisaroglu M., Konakc S., Ulukus C., Genc S., Genc K., Sagiroglu E., Cerami A., Brines M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl. Acad. Sci. USA 2002; 99: 2258-2263.
  6. Santhanam A.V., Katusic Z. S. Erythropoietin and cerebral vascular protection: role of nitric oxide. Acta Pharmacol. Sin. 2006; 27: 1389-1394.
  7. Siren A. L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., Ghezzi P. Erythropoietin prevent neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. USA 2001; 98: 4044-4049.
  8. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004; 35: 1732-1737.

Comments on this article